Align Technology, Inc.
NASDAQ:ALGNMedical - Devices
-$5.99 today
- Market cap
- $11.56B
- Beta
- 1.67
- P/E (TTM)
- 28.8
- EPS (TTM)
- $6.02
Volume 0.89M
Average 1.05M
ALGN EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Align Technology, Inc.NASDAQ: ALGN
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA declines year over year
Q2 FY2026 EBITDA of $90.53M fell 57.7% year over year, behind the -2.2% change in trailing-twelve-month EBITDA. Sequentially, it fell 55.9% from the prior quarter. Over 3 fiscal years it compounded at +1.8% a year.
Context
- EBITDA amounted to 20.4% of revenue in FY2025, unchanged from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 12 analysts of $1.41B (+71.6%) for the fiscal year ending Dec 2026, a step up from the +0.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $90.53M-55.9% QoQ
- Last fiscal yearDec 2025
- $822.72M+0.7% YoY
- LTMJun 2026
- $786.32M-2.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -57.7% | +35.7% | +93.4 pp |
| 1 year | +0.7% | +71.6% | +70.8 pp |
| 3-year CAGR | +1.8% | +23.7% | +21.9 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 822.72M USD
- Year-over-year change
- +0.7%
- 4-year CAGR
- -7.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 822.72M | +0.7% |
| FY2024 | 2024-12-31 | 816.8M | +2.2% |
| FY2023 | 2023-12-31 | 799.06M | +2.5% |
| FY2022 | 2022-12-31 | 779.84M | -30.4% |
| FY2021 | 2021-12-31 | 1.12B | — |
EBITDA vs competitors
How ALGN compares with its peers on the latest reported figures
- ALGN's LTM Jun 2026 EBITDA of $786.32M is the 2nd highest of the 3 companies compared; the peer median is $354.2M.
- Its year-over-year change of -2.2% is the lowest of 3, against a peer median of +114.5%.
- EBITDA amounts to 19.0% of revenue for ALGN, versus a peer median of 16.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Oct 2026 | $835.4M | +154.2% | -14.2% | 29.0% | |
| LTM Jun 2026 | $786.32M | -2.2% | +1.8% | 19.0% | |
| LTM Mar 2026 | -$127M | +74.8% | — | 3.5% | |
| Peer median (excluding ALGN) | $354.2M | +114.5% | -14.2% | 16.2% | |
Competitors are the stored peer set for ALGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.95B | 3.73B | 3.86B | 4B | 4.03B |
| Cost of Revenue | 1.02B | 1.1B | 1.16B | 1.2B | 1.28B |
| Gross Profit | 2.94B | 2.63B | 2.71B | 2.8B | 2.76B |
| Gross Margin | 74.3% | 70.5% | 70.1% | 70.0% | 68.3% |
| Research & Development | 250.32M | 305.26M | 346.83M | 364.2M | 369.91M |
| Selling, General & Admin | 1.71B | 1.67B | 1.7B | 1.76B | 1.76B |
| Operating Expenses | 1.96B | 1.99B | 2.06B | 2.19B | 2.14B |
| Depreciation & Amortization | 108.73M | 125.79M | 142.4M | 145.03M | 237.44M |
| EBITDA | 1.12B | 779.84M | 799.06M | 816.8M | 822.72M |
| EBITDA Margin | 28.4% | 20.9% | 20.7% | 20.4% | 20.4% |
| Operating Income | 976.4M | 642.6M | 643.34M | 607.63M | 616.22M |
| Operating Margin | 24.7% | 17.2% | 16.7% | 15.2% | 15.3% |
| Interest Income | 3.1M | 5.37M | 17.26M | 20.22M | 16.05M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 36.02M | (43.54M) | (2.13M) | 1.33M | (30.93M) |
| Income Before Tax | 1.01B | 599.06M | 641.2M | 608.96M | 585.29M |
| Pre-Tax Margin | 25.6% | 16.0% | 16.6% | 15.2% | 14.5% |
| Income Tax Expense | 240.4M | 237.48M | 196.15M | 187.6M | 174.94M |
| Net Income | 772.02M | 361.57M | 445.05M | 421.36M | 410.35M |
| Net Margin | 19.5% | 9.7% | 11.5% | 10.5% | 10.2% |
| EPS (Basic) | 9.78 | 4.62 | 5.82 | 5.63 | 5.66 |
| EPS (Diluted) | 9.69 | 4.61 | 5.81 | 5.62 | 5.65 |
| Weighted Avg Shares | 78.92M | 78.19M | 76.43M | 74.88M | 72.54M |
| Weighted Avg Shares (Diluted) | 79.67M | 78.42M | 76.57M | 74.99M | 72.59M |
Align Technology, Inc.
NASDAQ:ALGN
Intrinsic Alpha fair value
Locked
Current Price
$163.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.